246 related articles for article (PubMed ID: 21968508)
1. Type 2 idiopathic macular telangiectasia.
Shukla D; Gupta SR; Neelakantan N; Tiwari S; Gupta S; Patwardhan AR; Soubhya TB
Retina; 2012 Feb; 32(2):265-74. PubMed ID: 21968508
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
4. Retinal angiomatous proliferation: natural history and progression of visual loss.
Viola F; Massacesi A; Orzalesi N; Ratiglia R; Staurenghi G
Retina; 2009 Jun; 29(6):732-9. PubMed ID: 19516115
[TBL] [Abstract][Full Text] [Related]
5. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration.
Mruthyunjaya P; Stinnett SS; Toth CA
Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
7. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.
Lieb DF; Scott IU; Flynn HW; Miller D; Feuer WJ
Ophthalmology; 2003 Aug; 110(8):1560-6. PubMed ID: 12917173
[TBL] [Abstract][Full Text] [Related]
8. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2.
Toygar O; Guess MG; Youssef DS; Miller DM
Retina; 2016 Nov; 36(11):2150-2157. PubMed ID: 27258671
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
10. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
Zhang HR; Wang X; Lu XR; Yang YF; Liu F
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
[TBL] [Abstract][Full Text] [Related]
12. Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes.
Ando F; Ohba N; Touura K; Hirose H
Retina; 2007 Jan; 27(1):37-44. PubMed ID: 17218913
[TBL] [Abstract][Full Text] [Related]
13. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
[TBL] [Abstract][Full Text] [Related]
14. Retinal structural alterations and macular sensitivity in idiopathic macular telangiectasia type 1.
Takayama K; Ooto S; Tamura H; Yamashiro K; Otani A; Tsujikawa A; Yoshimura N
Retina; 2012 Oct; 32(9):1973-80. PubMed ID: 22487581
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG
Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
[TBL] [Abstract][Full Text] [Related]
16. Focal laser ablation of retinal angiomatous proliferation.
Johnson TM; Glaser BM
Retina; 2006 Sep; 26(7):765-72. PubMed ID: 16963849
[TBL] [Abstract][Full Text] [Related]
17. Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration.
Kumar N; Mrejen S; Fung AT; Marsiglia M; Loh BK; Spaide RF
Ophthalmology; 2013 Feb; 120(2):334-41. PubMed ID: 23137630
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cone pathologic changes in idiopathic macular telangiectasia types 1 and 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Ueda-Arakawa N; Tsujikawa A; Yamashiro K; Oishi A; Hanebuchi M; Yoshimura N
Am J Ophthalmol; 2013 Jun; 155(6):1045-1057.e4. PubMed ID: 23465268
[TBL] [Abstract][Full Text] [Related]
20. Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon's capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia.
Hirano Y; Yasukawa T; Usui Y; Nozaki M; Ogura Y
Br J Ophthalmol; 2010 May; 94(5):600-5. PubMed ID: 19846412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
